Objective: To systematically review studies examining risk factors for herpes zoster (HZ). Methods: We performed a literature search using PubMed, EMBASE, and Web of Science for articles published from January 1, 2003, to February 1, 2017. A random-effects model was used to summarize the risk ratio (RR) or odds ratio (OR) and 95% CI. Results: Of the 3450 studies screened, we included 84 studies in the systematic review and conducted meta-analysis in 62 studies. Women were at increased risk of HZ compared with men (pooled adjusted RR, 1.31; 95% CI, 1.27-1.34). Black individuals had almost half the risk of HZ as white individuals (pooled RR, 0.54; 95% CI, 0.47-0.63). Family history was found to be a risk factor for HZ (pooled OR, 3.59; 95% CI, 2.39-5.40). Autoimmune diseases, including rheumatoid arthritis (pooled RR, 1.67; 95% CI, 1.41-1.98) and systemic lupus erythematosus (pooled RR, 2.10; 95% CI, 1.40-3.15), were associated with an elevated risk of HZ. Other comorbidities were associated with an increased risk of HZ, with the pooled RRs ranging from 1.25 (95% CI, 1.13-1.39) for asthma to 1.30 (95% CI, 1.17-1.45) for diabetes mellitus and 1.31 (95% CI, 1.22-1.41) for chronic obstructive pulmonary disease. Conclusion: Our review revealed that female sex, race/ethnicity, family history, and comorbidities are risk factors for HZ. Efforts are needed to increase the uptake of zoster vaccination.
A fter a primary infection causing varicella (chickenpox), varicella-zoster virus (VZV) establishes latency in sensory ganglia and can reactivate later in life to cause herpes zoster (HZ) (shingles). 1 Herpes zoster causes a painful, blistering rash and can lead to postherpetic neuralgia (PHN), a persistent painful complication, particularly common in older patients. [2] [3] [4] Postherpetic neuralgia can substantially impair the physical, psychological, and social functioning aspects of patients' lives. 5 Patients with HZ can also experience other nonepain-related complications including HZ ophthalmicus with eye involvement. 6 Further, recent studies have found that HZ is associated with an increased risk of stroke in the first 3 months following shingles. 7 The incidence rate of HZ in the general population is between 3 and 5 per 1000 person-years, with a similar incidence reported in North America, Europe, and Asia-Pacific. 8 The incidence of HZ has increased over the past several decades independent of the aging demographic. [8] [9] [10] Further, the public health burden of HZ is expected to increase with the aging population across the world.
Well-recognized risk factors for HZ are age and immunocompromising conditions as cellmediated immunity declines. 11, 12 The risk of HZ is markedly increased with older age. The age-specific incidence rate is approximately 6 to 8 per 1000 person-years in adults at 60 years of age and 8 to 12 per 1000 person-years in adults at 80 years of age. 8 Further, the risk of HZ is elevated in patients with immunocompromising conditions, including bone marrow or solid organ transplant, hematologic and solid malignancies, and human immunodeficiency virus/AIDS. 12 Immunosuppressive medications, such as chemotherapy, high-dose corticosteroids, and biologic agents, are also known to increase the risk of HZ. 12 A live attenuated zoster vaccine is indicated for the prevention of HZ. 13 The US Advisory Committee on Immunization Practices currently recommends vaccination in adults 60 years of age and older. 12 A live attenuated zoster vaccine is contraindicated in immunocompromised patients or those receiving immunosuppressive therapy. A new adjuvanted zoster subunit vaccine has recently shown promising results in immunocompetent older adults and was approved by the US Food and Drug Administration. 14, 15 The vaccine is also currently being evaluated in immunocompromised individuals.
Better understanding of risk factors for HZ may provide valuable information for health care professionals to identify patients at heightened risk at all ages and could help formulate appropriate policy for vaccination strategy potentially targeted by factors other than age. A previous (2004) systematic review by Thomas and Hall 11 revealed age and immunosuppression as important risk factors but highlighted a lack of general understanding about determinants of HZ. Since then, numerous studies have investigated risk factors for HZ. The objective of our study was to systematically review studies examining risk factors for HZ and discuss implications based on the updated evidence.
METHODS

Literature Search
We performed a literature search using PubMed, EMBASE, and Web of Science. We used the following search strategy using PubMed: Medical Subject Headings (MeSH) for herpes zoster or the title terms for zoster or shingles in combination with the MeSH terms for risk, incidence, odds ratio, or proportional hazards models or the title/abstract terms for risk, odds ratio, proportional hazards, hazard ratio, incidence, or association. We used the similar search strategy for EMBASE and Web of Science. Our study built on the prior systematic review by Thomas and Hall. 11 Thus, we searched literature published between January 1, 2003, and February 1, 2017. We also manually searched the references cited by the retrieved articles and review articles for additional references.
Inclusion and Exclusion Criteria
Two investigators (K.K. and B.P.Y.) reviewed publications and selected eligible articles. We included studies that examined risk factors for HZ and reported measure of associations. We included only studies that evaluated the incidence of HZ. Only full-text articles in English were included. We excluded studies limited to children (18 years of age), immunocompromised populations (eg, bone marrow or solid organ transplant, hematologic and solid malignancies, and human immunodeficiency virus/AIDS), or other specific clinical groups. Conference abstracts, review articles, case series, and animal studies were also excluded.
Data Extraction and Quality Assessment
We collected information regarding authors, publication year, settings, study design, study population, outcome definition, measures of association, and adjusted confounding factors. In order to assess the quality of included observational studies, we evaluated study design, outcome definition, and adequate adjustment of confounding factors.
Statistical Analyses
We used a random-effects model to estimate the pooled risk ratio (RR) or odds ratio (OR) and 95% CI. The natural logarithms of the RRs and their corresponding SEs from individual studies were used to compute the pooled estimates. For studies that utilized the same data set from the same period, we included only one of the studies in the meta-analysis. We also assessed the I 2 statistic, which estimates the proportion of the total variation among studies due to heterogeneity rather than chance. As a subgroup analysis, we also examined the pooled estimates by study design (ie, cohort vs case-control studies). Publication bias was assessed by inspecting the asymmetry of a funnel plot and performing the Begg rank correlation test and the Egger regression test. All statistical analyses were conducted using Stata (StataCorp) and R, version 3.1.1 (R Project for Statistical Computing) statistical software.
RESULTS
Study Characteristics
Of the 3450 studies screened, we included 84 observational studies in the systematic review and conducted meta-analysis in 62 studies (Supplemental Figure, available online at http://www.mayoclinicproceedings.org). There were 27 studies that examined sex as a risk factor for HZ ( Supplemental Table, available online at http://www.mayoclinicproceedings. org). 3, 10, 11, The characteristics of 43 studies that examined race/ethnicity, family history, comorbidities, physical injury, psychological stress, and statins use are summarized in the Table. 10, 11, 21, 26, 30, [32] [33] [34] [35] Most of the included studies were retrospective cohort studies utilizing administrative claims or electronic medical records databases, and the remaining were prospective cohort studies or case-control studies with primary care data collection. Study populations ranged widely from a case-control study of 202 participants to a retrospective study using administrative data from approximately 51 million adults.
Most of the studies were adjusted for confounding factors (age, sex, immunosuppressive conditions, and comorbidities).
Demographic Characteristics and Family History
Twenty-seven studies that reported the incidence of HZ by sex were conducted in North America (United States and Canada), Europe (United Kingdom, Spain, France, Germany, Italy, Netherlands, and Israel), Australia, and Asia (Japan, Taiwan, and China) ( Supplemental Table) . 3, 10, 11, Almost all studies consistently reported that women are at increased risk of HZ compared with men (pooled RR, 1.31; 95% CI, 1.27-1.34) ( Figure 1 ).
Black individuals have about half the risk of HZ compared with white individuals (pooled RR, 0.54; 95% CI, 0.47-0.63). 10, 11, 26, 30, 40 A study of US adults aged 65 years or older using Medicare data found that compared with white individuals, black individuals (adjusted RR, 0.51; 95% CI, 0.48-0.53) and Hispanic individuals (RR, 0.76; 95% CI, 0.72-0.81) had a lower incidence of HZ, but Asian Americans had no difference in HZ risk (RR, 0.92; 95% CI, 0.76-1.12). 10 Comparable differences in the risk of HZ by race/ethnicity were also observed in studies from the United Kingdom and Spain. 11, 33 Five case-control studies consistently found that having first-degree blood relatives with a history of HZ is a risk factor for HZ (pooled OR, 3.59; 95% CI, 2.39-5.40). [41] [42] [43] [44] [45] 45 ).
Comorbidities
Rheumatoid arthritis (RA) was consistently associated with an increased risk of HZ in 5 studies (pooled RR, 1.67; 95% CI, 1.41-1.98), although the reported RR varied from 1.19 to 2.40 ( Figure 2) . 30, [46] [47] [48] [49] Reported HZ RRs for systemic lupus erythematosus (SLE) also varied widely from 1.29 to 4.11 among 4 studies, with a pooled RR of 2.10 (95% CI, 1.40-3.15). 30, [48] [49] [50] Inflammatory bowel disease was consistently associated with an increased risk of HZ among 5 studies (pooled RR, 1.35; 95% CI, 1.28-1.42). 30, 49, [51] [52] [53] Two studies reported that Crohn disease (adjusted RRs, 1.61 and 1.69) was associated with greater risk of HZ than ulcerative colitis (RRs, 1.21 and 1.34). 51, 52 Increased risks of HZ have also been reported in other autoimmune diseases, including psoriasis, type 1 diabetes, Sjögren syndrome, multiple sclerosis, dermatomyositis, and polymyositis. [74] [75] [76] [77] Chronic kidney disease was consistently associated with an increased risk of HZ (pooled RR, 1.28; 95% CI, 1.14-1.42). 30, 49, 54 Patients with end-stage renal disease have increased risk of HZ (RR, 1.98). 78 Further, patients who received a renal transplant (hazard ratio [HR], 8.46) and peritoneal dialysis (HR, 3.61) had an elevated risk of HZ. 79 Five studies consistently reported chronic obstructive pulmonary disease (COPD) being a risk factor for HZ (pooled RR, 1.31; 95% CI, 1.22-1.41) ( Figure 3 ). Elevated risk was observed especially in patients with COPD who were taking oral corticosteroids (adjusted RR, 3.00; 95% CI, 2.40-3.75). 55 Asthma was also associated with the increased risk of HZ in 6 studies (pooled RR, 1.25; 95% CI, 1.13-1.39). Several studies found asthma to be associated with risk of HZ even after adjusting for inhaled and systemic corticosteroid use. Forbes et al 49 reported that the association between asthma and risk of HZ was attenuated from 1.21 (95% CI, 1.17-1.25) to 1.11 (95% CI, 1.06-1.16) after adjusting for inhaled corticosteroids.
Diabetes mellitus (DM) was associated with an increased risk of HZ (pooled RR, 1.30; 95% CI, 1.17-1.45); however, the strength of the association varied widely among 14 studies. 21, 30, [32] [33] [34] [35] 43, 48, 49, 56, [59] [60] [61] [62] All studies except two 43, 48 utilized administrative claims or electronic medical records databases and were conducted in North America, Europe, and Asia. A study in Israel by Heymann et al 59 reported that the association between DM and risk of HZ did not differ by the level of glycated hemoglobin.
Depression was associated with an increased risk of HZ (pooled RR, 1.36; 95% CI, 1.15-1.61). 21, 35, 43, 45, 48, 49, 56, 63 Two case-control studies based on self-reported depression found greater risk of HZ 43 other studies that defined depression on the basis of diagnostic codes using administrative or medical record data. Additionally, a study in Taiwan found that patients with psychiatric disorders (including schizophrenia, psychoses, neurotic and personality disorders, and other mental disorders) had increased risk of HZ (adjusted RR, 1.29; 95% CI, 1.18-1.38). 80 Several studies evaluated other comorbidities, including allergic rhinitis, cardiovascular diseases, heart failure, hypertension, hyperlipidemia, and peptic ulcer disease. 21, 33, 81, 82 Physical Trauma, Psychological Stress, and Statin Use Four of 5 studies found physical trauma to be associated with an increased risk of HZ (pooled RR, 2.56; 95% CI, 1.97-3.33) ( Figure 4) . 45, 57, [64] [65] [66] Findings from studies examining psychological stress/negative life events are mixed. 40, 43, 45, [67] [68] [69] Three casecontrol studies found self-reported stress to be associated with an increased risk of HZ. 43, 45, 67 However, 2 recent studies of health care utilization databases found no evidence of increased risk of HZ after a catastrophic health event or death of a partner. 68, 69 Statin use was associated with an increased risk of HZ among 3 studies (pooled RR, 1.14; 95% CI, 1.11-1.17). 70, 72, 73 Antoniou et al 70 did not observe a dose-response relationship; however, Matthews et al 73 found that risk of HZ increased when statin dosages were increased (P<.001 for trend).
There was suggested evidence of potential publication bias in the association between sex and risk of HZ (Begg rank test, P¼.69; Egger test, P¼.01). However, most of the studies were large database studies, and it is unlikely that selective publication may have occurred. Publication bias was not evident for any of the other risk factors reported.
Other Risk Factors
Several studies found socioeconomic status to be associated with risk of HZ; however, results are inconsistent as to the direction of the association. Higher socioeconomic status was associated 
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with higher risk in studies in the United States and Israel but lower risk in Spain. 30, 32, 33 Four of 5 studies reported reduced risk of HZ from active cigarette smoking. 11, 35, 57, 83, 84 A community-based prospective cohort study of 12,351 adults in Japan found that current vs never smoking was associated with about half the risk of development of HZ (adjusted HR, 0.52; 95% CI, 0.33-0.81). 84 Hope-Simpson 1 hypothesized that contact with individuals with varicella may decrease the risk of HZ. However, there is no consistent evidence for protective effects of varicella contacts. Several studies found that frequent exposure to varicella may decrease the risk of HZ [85] [86] [87] [88] ; however, other studies found no evidence for such effects. [89] [90] [91] Of note, a study in France found no differences in the frequency of HZ when comparing a group of monks and nuns who had virtually no contact with children vs the general population (16.2% vs 15.1%; P¼.27). 91 Other risk factors examined on a limited basis include genetics, nutrition, coinfection with herpes simplex virus, and environmental factors. Polymorphism of the interleukin 10 gene (IL10) was associated with risk of HZ in 2 studies. 92, 93 One of the studies, conducted in Finland, found that the ATA haplotype of IL10, which is associated with low production of IL-10, was more common in patients with HZ than in those without HZ (53% vs 38%; P<.05). 92 Additionally, genetic variations in the HLA antigen region and mitochondrial haplogroups have also been suggested as being associated with risk of HZ. 94, 95 A case-control study reported that frequent intake of vegetables and fruits decreases the risk of HZ. 96 One study found coinfection with herpes simplex to be a risk factor for HZ. 56 Results from 2 studies conducted in China and Taiwan suggested that temperature may affect the risk of HZ. 97, 98 
DISCUSSION
Our review summarizes that female sex, race/ ethnicity, family history, autoimmune diseases (RA, SLE, and inflammatory bowel disease), other comorbidities (chronic kidney disease, COPD, DM, asthma, and depression), physical injury, and statin use are risk factors for HZ. Our study includes additional literature published since the last systematic reviews were conducted almost a decade ago. 11, 12 Further, to our knowledge, we are the first to conduct a meta-analysis to quantitatively synthesize the results.
Women are at increased risk of HZ compared with men, likely because of sex differences in health careeseeking behavior but also possibly because of immunologic or hormonal mechanisms. Women had higher incidence rates of HZ than men in the placebo group (11.79 vs 10.65 per 1000 person-years) in the trial of HZ vaccine. 13 Because participants were actively followed up every month in the trial, this finding suggests that biological factors may also be responsible for sex differences in the risk. Black individuals have about half the risk of development of HZ as white individuals, which potentially could be due to differences in genetic risk, access to health care, and/or health careeseeking behaviors. Family history was consistently found to be a risk factor for HZ, suggesting genetic predispositions because the cases in relatives were not temporally linked. Having a first-degree blood relative with a history of HZ was associated with an almost 3-fold increased risk of HZ. Because of case-control study design, results may have been overestimated because patients with HZ are more likely to have shared their experience with relatives and be aware of relatives' history of HZ than those without HZ. Strong associations of family history with risk of HZ are supported by genetic studies. 92, 93 Results from one study also suggest that genomic variation in the HLA antigen region may increase susceptibility to HZ, which has also been reported in other infectious diseases. 95, 99 Autoimmune diseases, including RA and SLE, were associated with an almost 2-fold elevated risk of HZ, with reported incidence rates of 8 to 15 per 1000 person-years. 46, 47, 100 Inflammatory bowel disease was also found to be a risk factor for HZ. Reported RRs varied by studies, which may be partly due to differences in the prevalence of immunosuppressive medications among studies. Increased risk of HZ from immunosuppressive medications is discussed in a recent review by Marra et al. 101 The live attenuated HZ vaccine is contraindicated among those taking antietumor necrosis factor therapies or other biological agents and is recommended before receiving these medications. 100 Nonlive recombinant vaccine may become available in the near future among immunocompromised individuals.
Other comorbidities that have been associated with risk of HZ include chronic kidney disease, COPD, DM, asthma, and depression, with the pooled RR of approximately 1.3. The modestly increased risk of HZ from use of statins is another important recent finding. Diabetes mellitus and COPD are becoming increasingly more prevalent, with the prevalence of 8.5% for DM and 11.7% for COPD worldwide. 102, 103 The prevalence of DM is estimated to be 26% among US adults older than 65 years. Although the increased risk may be relatively small, attributable risks associated with prevalent medical conditions may be substantial from a public health perspective. The US Advisory Committee on Immunization Practices currently recommends vaccinating adults 60 years of age and older; however, it may be worth considering vaccinating at a younger age among adults with underlying comorbidities found to be associated with heightened HZ risk. It is also important to understand whether individuals with underlying comorbidities are at increased risk of complications, particularly PHN. A recent study found that autoimmune disease, depression, COPD, and DM may increase the risk of PHN, although more research is needed to confirm the findings. 104 
Biological Plausibility
The biological mechanism for most risk factors for HZ can be explained by impaired cellmediated immunity. Patients with autoimmune disease are at increased risk of HZ because of their underlying impaired immunity and use of immunosuppressive medications. Patients with DM have decreased VZV-specific cell-mediated immunity. 105 Depression activates inflammatory response and is associated with reduced VZV-specific cell-mediated immune response. 106 Immune dysfunction and imbalance of proinflammatory and anti-inflammatory cytokines may potentially play a role in reactivation of VZV infection. In the genetic studies, polymorphism of the IL10 gene was associated with risk of HZ. Low production of antiinflammatory cytokine IL-10 leads to higher production of inflammatory cytokines, such as IL-6 and tumor necrosis factor a. Of note, astronauts are found to be at increased risk of VZV reactivation during their space flight, partly due to elevated levels of IL-6 and helper T cell type 2 cytokine IL-4. 107 Further, patients with autoimmune disease have elevated levels of IL-6, which may partially explain their increased risk of HZ.
Environmental factors, coinfections, or other biological factors may also possibly play a role in reactivation of VZV infection. It is still difficult to explain the triggers for reactivation in healthy adults. Further, the cause of the temporal increase in the incidence of HZ in the past several decades remains unknown. Unexpectedly, several studies consistently found that active smoking reduces the risk of HZ. Thus, there may be unknown biological mechanisms responsible for development of HZ, and further research is required.
Limitations and Future Areas of Research
Because of substantial heterogeneity in the relative risks, pooled estimates for some factors should be interpreted with caution. More research is needed to understand sources of heterogeneity. For example, it is important to understand whether the association between DM and risk of HZ can be explained by different levels of glycemic control. Further, there is inconsistent evidence for psychological stress and risk of HZ. Mixed results may be due to the differences in the definition of stress (acute vs chronic stress, severity or duration of stress, and cumulative stress), and further research should focus on better defining stress. The majority of studies adjusted for age, sex, immunocompromising conditions, and comorbidities. However, studies were often based on administrative or electronic medical record databases, and misclassification of exposures due to coding errors or unmeasured or inadequate adjustment of confounding factors may have biased the results. More research is required to examine modifiable risk factors, such as physical activities, diet, and environmental exposures.
CONCLUSION
In addition to age and immunocompromising conditions, our systematic review revealed that female sex, race/ethnicity, family history, and comorbidities are important risk factors for HZ. Health care professionals may consider recommending vaccine to adults 50 years of age or older, especially those who are at heightened risk of HZ. More efforts are needed to increase the uptake of current and new HZ vaccines.
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